Feb 12, 2018, 1:00:00 AM

GenomeWeb – Proteomics International Investing in CPR Pharma Services

NEW YORK (GenomeWeb) – Proteomics International said today it has entered a strategic alliance with CPR Pharma Services focused on clinical trials and related research.

Article: Proteomics International Investing in CPR Pharma Services

2018

PERTH, W. AUSTRALIA, Feb 12, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International...

PERTH, W. AUSTRALIA — MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a...

The Company is pleased to advise it has received ISO 13485 certification, the most widely-used...

GenomeWeb – Proteomics International Investing in CPR Pharma Services

Related posts

ACN Newswire – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development

Business News Asia – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services

Proteomics International achieves ISO 13485 certification